Chen Bing Wu

Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA.

Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA.

Anchor Therapeutics, Inc. designs and develops peptide modulators of G protein-coupled receptors (GPCRs). The firm engages in developing and licensing pepducin technology as a research tool for drug development; and pepducin drug candidates and novel molecules that are intended for targeting GPCR to allosterically modulate GPCR signaling. Its pepducin lipopeptides are designed to allosterically modulate internal cell signaling via specific interactions with intracellular GPCR domains. The company also focuses on developing its pepducin technology for creating new treatment options for regenerative medicine, diabetes, inflammation, and cancer. Anchor Therapeutics was founded by Thomas J. McMurry and Athan Kuliopulos in 2006 and is headquartered in Cambridge, MA.

Niveus Medical, Inc. provides stimulation to quadriceps. It indicates for relaxation of muscle spasms, muscle re-education of the quadriceps and increasing local blood circulation. The company was founded by Brian Fahey on October 8, 2008 and is headquartered in Redwood City, CA.

Medina Medical, Inc. operates as a neurovascular company. The firm provides minimally-invasive devices for the treatment of brain aneurysms and stroke. The company was founded by Maria Aboytes and Kimberly Vogel in 2010 and is headquartered in Menlo Park, CA.

Institutional Venture Partners (Institutional Venture Partners) is a venture capital firm founded in 1980 by Reid Dennis. The firm is headquartered in Menlo Park, California.

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS) in the US. Headquartered in New York City, the firm was founded in 1987 and provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.

Abbott Cardiovascular Systems, Inc. manufactures medical devices. It also makes cardiac and peripheral vascular repair surgical systems. The company was founded in 1978 and is headquartered in Santa Clara, CA.

The Foundry LLC provides investment services to medical device companies. It includes the inventor partners of business development, product development and prototyping, market analysis and development, human resources and recruitment and intellectual property enterprise. The company was founded by Allan R Will and Henry A. Plain, Jr. in 1998 and is headquartered in Menlo Park, CA.

Bay City Capital LLC (Bay City Capital) is a venture capital firm founded in 1997 by Fred Craves, John Diekman, and Thomas Pritzker. The firm is headquartered in California, United States.

Beijing SinceTimes Communication Co., Ltd. develops mobile application software solutions. The company is headquartered in Beijing, China.

Shanghai ChemPartner Co., Ltd. operates as a contract research organization. It provides chemistry, biology, pharmacology, DMPK, process R&D, pre-formulation, and analytical development services to global pharmaceutical and biotech companies. The company was founded in 2003 and is headquartered in Shanghai, China.

Part of Aranz Healthcare Ltd., Aranz Medical Ltd. is a medical device company based in Christchurch, New Zealand. The New Zealander company specializes in innovative medical image-capture devices and recording, reporting, and analysis software. The company's solutions are primarily used to document chronic wounds and skin conditions, and are well suited to both clinical trial and clinical practice applications. The company's flagship product, Silhouette®, is a wound imaging, measurement, and documentation system that supports more accurate wound assessment. The company was founded in 2005 by Rick Fright and Mark Nixon, and Bruce Davey has been the CEO of the company since 2010.

Jiangsu Yasheng Pharmaceutical Development Co. Ltd. develops and produces pharmaceutical products. It focuses on research and development of structure-based molecule for cancer drugs. The company was founded by Dajun Yang, Ming Guo, and Shaomeng Wang in 2009 and is headquartered in Hong Kong.

Nalu Medical, Inc. is a medical technology company, which develops, manufactures, and commercializes invasive solutions for patients with chronic neuropathic pain. It markets Nalu neurostimulation system that delivers gentle electrical pulses to the nervous system to modulate pain signals to the brain. The company was founded by Keegan Harper, Lee Hartley, Mike Partsch, and Daniel Pivonka in October 28, 2014 and is headquartered in Carlsbad, CA.

Shenzhen GeneMDx Biotech Co., Ltd. manufactures biologique products. It engages in domestic sales of medical equipments and diagnosis reagents. The company was founded on June 23, 2011 and is headquartered in Shenzhen, China.

Abcuro, Inc. develops bio-therapeutics for the treatment of autoimmunity and cancer. the company was founded in 2015 and is headquartered in Newton, MA.

Harbour Biomed Shanghai Co. Ltd. engages in the development of therapeutics for cancer, especially in immuno-oncology. The company is headquartered in Shanghai, China.

Shangbay Capital Management Co. LLC (Shangbay Capital) is a venture capital firm founded in 2015. The firm is headquartered in Palo Alto, California.

ShangPharma Innovation Inc. (ShangPharma Innovation) is a venture capital firm, a subsidiary of Shangpharma Investment Group Ltd. founded in 2016. The firm is headquartered in San Francisco, California.

Arrinex, Inc. operates as a funded medical device company. It develops medical procedure that is used in patients with refractory chronic rhinitis. The firm develops disruptive cryotherapy technology for treating chronic nasal allergy symptoms: congestion and drainage. The company was founded by Vahid Saadat and Mojgan Saadat and is headquartered in Redwood City, CA.

HotSpot Therapeutics, Inc. develops new allosteric therapies with the ability to treat disease. The company was founded by Jonathan Montagu and Geraldine Harriman and is headquartered in Boston, MA.

Take2 Consulting LLC operates a platform for collaborative IT support resources. It offers cyber security, devops, mobility, big data, and engineering solutions. The company was founded by Serge Khoury in 2014 and is headquartered in Vienna, VA.

Cellares Corp. operates as a biotechnology company. It provides preclinical and clinical scientists as well as commercial cell therapy manufacturers. The company was founded by Omar Kurdi, Fabian Gerlinghaus and Alex Pesch in 2019 and is headquartered in South San Francisco, CA.

Part of Illumina, Inc., Cirina, Inc. operates medical laboratories.

Watchmaker Genomics, Inc. applies advanced enzymology to enable breakthrough applications for the reading, writing, and editing of DNA and RNA. Based in Boulder, CO, the Watchmaker team brings decades of collective experience building successful life science companies, commercializing novel technologies, and advancing clinical genomics applications. The company's product portfolio includes enzymes and kits for next-generation sequencing library preparation, synthetic biology, and molecular diagnostics. Watchmaker partners directly with innovative life science companies, commercial sequencing providers, and pioneering research labs. The CEO of the company is John F. Foskett.

Aim-Hi Accelerator Fund, Inc. is a non-profit company that was born out of the National Foundation for Cancer Research (NFCR). The company is based in Rockville, MD. The company aims to bridge the gap between innovative, early-stage cancer research and successful development of high-impact oncology products. Aim-Hi is a new paradigm to fund translational research designed to focus on startups that have commercial potential at cancer therapeutic discovery. The company was founded by Sujuan Ba, Charlie Weatherspoon, Franklin Cary Salisbury. Sujuan Ba has been the CEO since incorporation.